Pathophysiology and Management of Insomnia During Depression

References

• Katon W, Schulberg H: Epidemiology of depression in pri-mary care. Gen Hosp Psychiatry 1992; 14:237–247
   PubMed Web of Science ®Google Scholar
• Coyne IC, Fechner-Bates S, Schwenk TL: Prevalence, nature and comorbidity of depressive disorders in primary care. Gen Hosp Psychiatry 1994; 16:267–276
   PubMed Web of Science ®Google Scholar
• Katon W: The epidemiology of depression in medical care. Int J Psychiatry Med 1987; 17:93–112
   PubMed Web of Science ®Google Scholar
• Perez-Stable EJ, Miranda J, Munoz RF, Ying Y-W: Depres-sion in medical outpatients: Underrecognition and misdiagno-sis. Arch Intern Med 1990; 150:1083–1088
   PubMed Web of Science ®Google Scholar
• Winokur A, Reynolds CF: The effects of antidepressants and anxiolytics on sleep physiology. Primary Psychiatry 1994; November/December: 19–25
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994;320–327
   Google Scholar
• Berger M, Lund R, Bronisch T, von Zerssen D: REM latency in neurotic and endogenous depression and the cholinergic REM induction test. Psychiatry Res 1983; 10:113–123
   PubMed Web of Science ®Google Scholar
• Bixler EO, Kales A, Soldatos CR, Kales JD, Healey S: Preva-lence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979; 136:1257–1262
   PubMed Web of Science ®Google Scholar
• Mellinger GD, Baiter MB, Uhlenhuth EH: Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985; 42:225–232
   PubMed Web of Science ®Google Scholar
• Ford DE, Kamerow DB: Epidemiologic study of sleep distur-bances and psychiatric disorders: An opportunity for preven-tion? JAMA 1989; 262:1479–1484
   PubMed Web of Science ®Google Scholar
• Frisoni GB, De Leo D, Rozzini R, Bernardini M, Della Buono M, Trabucchi M: Psychic correlates of sleep symptoms in the elderly. Int J Geriatric Psychiatry 1992; 7:891–898
   Google Scholar
• Frederick T, Frerichs RR, Clark VA: Personal health habits and symptoms of depression at the community level. Prevent Med 1988; 17:173–182
   PubMed Web of Science ®Google Scholar
• Bliwise DL, King AC, Harris RB, Haskell WL: Prevalence of self-reported poor sleep in a healthy population aged 50–65, Soc Sci Med 1992; 34: 49–55
   Google Scholar
• Soldatos CR: Insomnia in relation to depression and anxiety: Epidemiologic considerations. J Psychosom Res 1994; 38:3–8
   PubMed Web of Science ®Google Scholar
• Breslau N, Roth T, Rosenthal L, Andreski P: Sleep distur-bance and psychiatric disorders: A longitudinal epidemiologi-cal study of young adults. Biol Psychiatry 1996; 39:411–418
   PubMed Web of Science ®Google Scholar
• Kupfer DJ: Neurophysiological "markers"-EEG sleep mea-sures. J Psychiatr Res 1984; 18:467–475
   Google Scholar
• Reynolds CF III, Kupfer DJ: Sleep research in affective illness:State of the art circa 1987. Sleep 1987; 10:199–215
   Google Scholar
• Rush AJ, Erman MK, Giles DE, Schlesser MA, Carpenter G, Vasavada N, Roffwarg HP: Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry 1986; 43:878–884
   PubMed Web of Science ®Google Scholar
• Sharpley AL, Cowen Pk Effect of pharmacologic treatments on sleep of depressed patients. Biol Psychiatry 1995; 37:85–98
   PubMed Web of Science ®Google Scholar
• Giles DE, Biggs MM, Rush AJ, Roffwarg HP: Risk factors in families of unipolar depression: Psychiatric illness and re-duced REM latency. J Affect Disord 1988; 14:51–59
   Google Scholar
• Taylor DP, Eison MS, Riblet LA, Temple DL Jr, Yevich JP, Smith DW: Selective 5-HT2receptor blockade: Pharmacologi-cal studies of BMY 13754, a nontricyclic antidepressant candi-date. Soc Neurosci Abstr 1982; 8:465
   Google Scholar
• Ball EM: Sleep disorders in primary care. Compr Ther 1997; 23:25–30
   Google Scholar
• Bond T, Wooten V: The etiology and management of insom-nia. Va Med Q 1996; 123:254–255
   Google Scholar
• Ware JC, Morewitz J: Diagnosis and treatment of insomnia and depression. J Clin Psychiatry 1991; 52:55–61
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed., Revised. Washington, DC: American Psychiatric Association; 1987:218–224
   Google Scholar
• Reynolds CF, Shipley JE: Sleep in depressive disorders. In: Hales RE, Frances AJ, eds. Psychiatry Update: The American Psychiatric Association Annual Review, Vol. 4. Washington, DC: American Psychiatric Press; 1985:341–351
   Google Scholar
• Gitlin JC, Ancoli-Israel S, Erman M: Sleep and sleep-wake disorders. In: Tasman A, Kay J, Lieberman JA, Eds. Psychia-try, 2nd ed. Philadelphia: WB Saunders Co.; 1996:1217–1248
   Google Scholar
• Wehr TA:Improvement of depression and triggering of mania by sleep deprivation. JAMA 1992; 267:548–551
   Web of Science ®Google Scholar
• Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE Jr: Effect of steep deprivation on brain metabo-lism of depressed patients. Am J Psychiatry 1992; 149:538–543
   PubMed Web of Science ®Google Scholar
• Ebert D, Feistel H, Barock a A, Kaschka W. Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res 1994; 55:101–109
   Google Scholar
• Ho AP, Gillin JC, Buchsbaum MD, Wu JC, Abel L, Bunney WE Jr: Brain glucose metabolism during non-rapid eye move-ment in major depression: A positron emission tomography study. Arch Gen Psychiatry 1996; 53:645–652
   Google Scholar
• Berger M, Riemann D, Krieg JC: Cholinergic drugs as diag-nostic and therapeutic tools in affective disorders. Acta Psychiatr Scand Suppl 1991; 83:52–60
   Google Scholar
• Gillin JC, Sutton L, Ruiz C, Kelsoe J, Dupont RM, Darko D, Risch SC, Golshan S, Janowsky D: The cholinergic rapid eye movement induction test with arecoline in depression. Arch Gen Psychiatry 1991; 48:264–270
   PubMedGoogle Scholar
• Sharpley AL, Walsh AES, Cowen PJ: Nefazodone-a novel antidepressant-may increase REM sleep. Biol Psychiatry 1992; 31:1070–1073
   PubMed Web of Science ®Google Scholar
• Lawlor BA, Newhouse PA, Balkin TJ, Molchan SE, Mellow AM, Murphy DL, Sunderland T: A preliminary study of the effects of nighttime administration of the serotonin-agonist, m-CPP, on sleep architecture and behavior in healthy volun-teers. Biol Psychiatry 1991; 29:281–286
   PubMedGoogle Scholar
• Dingemanse J: Pharmacotherapy of insomnia: Practice and prospects. Pharm World Sci 1995; 17:67–75
   Google Scholar
• Coleman RM, Roffwarg HP, Kennedy SG, Guilleminault C, Cinque J, Cohn MA, Karacan I, Kupfer DJ, Lemmi H, Miles LE, Orr WC, Phillips ER, Roth T, Sassin JF, Schmidt HS, Weitzman ED, Dement WC: Sleep-wake disorders based on a polysonmographic diagnosis. JAMA 1982; 247:997–1003
   PubMed Web of Science ®Google Scholar
• Armitage R, Yonkers K, Cole D, Rush AJ: A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in de-pressed outpatients. J Clin Psychopharmaco11997; 17:161–168
   PubMed Web of Science ®Google Scholar
• Hammond EC: Some preliminary findings on physical com-plaints from a prospective study of 1,064,004 men and women. Am J Public Health 1964; 54:11–23
   PubMed Web of Science ®Google Scholar
• Rake RE: Insomnia: Concerns of the family physician. J Fam Pract 1993; 36:551–558
   Google Scholar
• Eaton WE, Badawi M, Melton B: Prodromes and precursors: Epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 1995; 152:967–972
   PubMed Web of Science ®Google Scholar
• The Gallup Organization: Sleep in America: A National Sur-vey of U.S. Adults. Houston, TX: for the National Sleep Foundation; 1991
   Google Scholar
• Bonnet MH, Arand DL: We are chronically sleep deprived. Sleep 1995; 18:908–911
   PubMed Web of Science ®Google Scholar
• Diagnostic Classification Steering Committee, Thorpy MJ, Chairman: ICSD-International Classification of Sleep Dis-orders: Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association; 1990
   Google Scholar
• Kupfer DJ, Reynolds CF: Management of insomnia. N Engl J Med 1997; 336:341–346
   PubMed Web of Science ®Google Scholar
• Coleman RM: Diagnosis, treatment, and follow-up of about 8,000 sleep/wake disorder patients. In: Guilleminault C, Lu-garesi E, Eds. Sleep/Wake Disorders: Natural History, Epide-miology, and Long-Term Evolution. New York: Raven Press; 1983:87–97
   Google Scholar
• Hauri P: Primary insomnia. In: Kryger MH, Roth T, Dement WC, Eds. Principles and Practice of Sleep Medicine. Philadel-phia: WB Saunders; 1989:442–447
   Google Scholar
• Reynolds CF, Kupfer DJ: Sleep in depression. In: Williams RL, Karacan I, Moor CA, Eds. Sleep Disorders: Diagnosis and Treatment. New York: John Wiley & Sons; 1988:147–164
   Google Scholar
• Becker PM, Jamieson AO, Brown WD: Insomnia: Use of a decision tree to assess and treat. Insomnia 1993; 93:66–85
   Google Scholar
• Brunton SA: When your patient can't sleep. Fam Pract Recer-tification 1992; 14:149–170
   Google Scholar
• Morin CM, Kwentus JA: Behavioral and pharmacological treatments for insomnia. Ann Behav Med 1988; 10:91–100
   Google Scholar
• Morin CM, Colecchi C, Stone J, Sood R, Brink D: Behavioral and pharmacological therapies for late-life insomnia: A ran-domized control trial. JAMA 1999; 281:991–999
   PubMed Web of Science ®Google Scholar
• Pary R, Tobias CR, Webb WK, Lippmann SB: Treatment of insomnia, getting to the root of sleeping problems. Insomnia 1996; 100:195–210
   Google Scholar
• Gregor KJ, Riley JA, Downing DK: Concomitant use of anxi-olytics and hypnotics with selective serotonin reuptake inhibi-tors. Clin Ther 1996; 18:521–527
   PubMed Web of Science ®Google Scholar
• Rascati K: Drug utilization review of concomitant use of spe-cific serotonin reuptake inhibitors or clomiprarnine with antianxiety/sleep medications. Clin Ther 1995; 17:786–790
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Conference: Consensus Devel-opment Conference Summary: Drugs and Insomnia. Bethesda, MD: National Institutes of Health; 1984; 4(10):1–9
   Google Scholar
• Roth T, Roehrs TA: A review of the safety profiles of benzodi-azepine hypnotics. J Clin Psychiatry 1991; 52:38–41
   PubMedGoogle Scholar
• Livingston MG: Benzodiazepine dependence. Br J Hosp Med 1994; 51:281–286
   PubMed Web of Science ®Google Scholar
• Evans SM, Critchfield TS, Griffiths RR: Abuse liability assess-ment of amdolytics/hypnotics: Rationale and laboratory lore. Br J Addict 1991; 86:1625–1632
   Google Scholar
• Rosholm J-U, HaIlas J, Gram LF: Concurrent use of more than one major psychotropic drug (polypharmacy) in outpa-tients-a prescription database study. Br J Clin Pharmacol 1994; 37:533–538
   PubMed Web of Science ®Google Scholar
• Nolen WA, Haffmans PM, Bouvy PF, Duivenvoorden HJ: Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lor-metazepam in patients with major depression, treated with a (tri)cyclic antidepressant. J Affect Disord 1993; 28:179–188
   Google Scholar
• Kuitunen T, Mattila MJ, Seppala T: Actions and interactions of hypnotics on human performance: Single doses of zopi-clone, triazolam, and alcohol. Int Clin Psychopharmacol 1990; 5\(suppl 2):115–130
   Google Scholar
• Haefely W: Benzodiazepine receptor and ligands: Structural and functional differences. In: Hindmarch I, Beaumont G, Brandon S, Leonard BE, Eds. Benzodiazepines: Current Con-cepts. Chichester: John Wiley & Sons; 1990:1–18
   Google Scholar
• SalvA P, Costa J: Clinical pharmacokinetics and pharmacody-namics of zolpidem. Clin Pharmacokinet 1995; 29:142–153
   PubMed Web of Science ®Google Scholar
• Hartmann PM: Drug treatment of insomnia: Indications and newer agents. Am Fam Physician 1995; 51:191–194
   Google Scholar
• Brunner DP, Dijk DJ, Munch M, Borbely AA: Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology (Berl) 1991; 104:1–5
   PubMed Web of Science ®Google Scholar
• Zolpidem: A hypnotic with a difference? Drug Ther Bull 1995; 33:37–39
   Google Scholar
• Palminteri R, Narbonne G: Safety profile of zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL, Eds. Imidazopyridines in Sleep Disorders. New York: Raven Press; 1988:351–361
   Google Scholar
• Crismon ML, Jermain DM: Sleep aid and stimulant products. In: Covington TR, Berardi RR, Young LL, Kendall SC, Hickey MJ, Eds. Handbook of Nonprescription Drugs. Wash-ington, DC: American Pharmaceutical Association; 1996: 135–146
   Google Scholar
• Gillin JC, Byerley WF: The diagnosis and management of insomnia. N Engl J Med 1990; 322:239–248
   PubMed Web of Science ®Google Scholar
• Roehrs T, Zwyghuizen-Doorenbos A, Roth T: Sedative ef-fects and plasma concentrations following single doses of tria-zolam, diphenhydramines, ethanol and placebo. Sleep 1993; 16:301–305
   PubMed Web of Science ®Google Scholar
• Gengo F, Gabos C, Miller JK: The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance. Clin Pharmacol Ther 1989; 45:15–21
   PubMed Web of Science ®Google Scholar
• Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL: Correlation between plasma diphenhydramine level and seda-tive and antihistamine effects. Clin Pharmacol Ther 1978; 23:375–382
   PubMed Web of Science ®Google Scholar
• Dolberg OT, Hirsclunann S, Grunhaus L: Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998;155:1119–1121
   PubMed Web of Science ®Google Scholar
• Zhdanova IV, Wurtman RJ, Lynch HJ, Ives JR, Dollins AB, Morabito C, Matheson JK, Schomer DL: Sleep-inducing ef-fects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995; 57:552–558
   PubMed Web of Science ®Google Scholar
• Butler RN: A wake-up call for caution. If insomnia is the patient's problem, is over-the-counter melatonin the cure? Geriatrics 1996; 51:14–15
   Google Scholar
• Middleton BA, Stone BM, Arendt J: Melatonin and frag-mented sleep pattern. Lancet 1996; 348:551–552
   PubMed Web of Science ®Google Scholar
• MendeIs J: Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients. J Clin Psychiatry 1994; 55:60–65
   Google Scholar
• American Psychiatric Association: Physiologic dependence on benzodiazepines. In: Salzman C, Ed. Benzodiazepine De-pendence, Toxicity, and Abuse: A Task Force Report of the American Psychiatric Association. Washington, DC: Ameri-can Psychiatric Association; 1990:15–23
   Google Scholar
• Cohn 113: Triazolam treatment of insomnia in depressed pa-tients taking tricyclics. J Clin Psychiatry 1983; 44:401–406
   Google Scholar
• Dominguez RA, Jacobson AF, Goldstein BJ, Steinbook RM: Comparison of triazolam and placebo in the treatment of insomnia in depressed patients. Curr Ther Res. 1984; 36:856–865
   Web of Science ®Google Scholar
• Vgontzas AN, Kates A, Baler EO: Benzodiazepine side ef-fects: Role of pharmacokinetics and pharmacodynamics. Pharmacology 1995; 51:205–223
   PubMed Web of Science ®Google Scholar
• Kales A, Soldatos CR, Bider EO, Kales JD: Rebound insom-nia and rebound anxiety: A review. Pharmacology 1983; 26:121–137
   PubMed Web of Science ®Google Scholar
• Birder EO, Kales A, Brubaker BH: Adverse reactions to ben-zodiazepine hypnotics: Spontaneous reporting system. Phar-macology 1987; 35:286–300
   Google Scholar
• Smith WT, Londborg PD, Glaudin V, Painter JR: Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: A double-blind study. Am J Psychiatry 1998; 155:1339–1345
   Google Scholar
• Allard 5, Sainati S, Roth-Schechter B, Macintyre J: Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women. Drug Metab Dispos 1998; 26:617–622
   PubMed Web of Science ®Google Scholar
• Rosenberg R, Scharf M, Ware JC, Walsh JK: Zolpidem im-proves sleep of SSRI-treated depressed patients with persis-tent insomnia. Sleep 1998; 21:136
   Google Scholar